Valiant Laboratories vs Peers
- Market cap
- ₹657 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹87.08 – ₹163.27
Valiant Laboratories ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are Valiant Laboratories. Its P/E of 22.5 compares with a peer median of 22.5.
Valiant Laboratories vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Valiant Laboratories | 120.94 | -1.84% | 657 | 22.5 | 2.85 | 14.5% | +18.5% |
| Valiant Laboratories | 120.94 | -1.84% | 657 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Valiant Laboratories peer comparison — frequently asked questions
Who are Valiant Laboratories' competitors?
Valiant Laboratories' listed peers in Drug Manufacturers - Specialty & Generic include Valiant Laboratories, ranked here by market capitalisation.
How does Valiant Laboratories' P/E compare with its peers?
Valiant Laboratories trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Valiant Laboratories' peers?
By market capitalisation, the largest company in the group is Valiant Laboratories at ₹657 crore, against ₹657 crore for Valiant Laboratories.
Same Data For Peers
Trade Valiant Laboratories With ATS
Track VALIANTLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.